Balance Sheet Medpace Holdings, Inc.

Equities

MEDP

US58506Q1094

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2025-12-05 EST			5-day change	1st Jan Change
548.12 ^USD	+0.61%		-7.48%	+64.98%

12-03	Medpace Holdings Insider Sold Shares Worth $17,114,847, According to a Recent SEC Filing	MT
12-01	Medpace Holdings Insider Sold Shares Worth $34,074,470, According to a Recent SEC Filing	MT

a3d0edbc47034.LCQk70-4WaOaFVC-qEgwAe2CqZZHvrfHFFUQPsn919o.XnBshRb1Nu2sQybZmxdJZ6jkhPtq14CrITdeWrq0goJAdEWeBIku4MhHPw

Published financial data: MEDPACE HOLDINGS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	926M	1.14B	1.46B	1.89B	2.11B
Total Revenues	926M	1.14B	1.46B	1.89B	2.11B
Cost of Goods Sold, Total	354M	441M	535M	638M	682M
Gross Profit	571M	701M	925M	1.25B	1.43B
Selling General & Admin Expenses, Total	92.16M	108M	131M	161M	180M
Depreciation & Amortization - (IS)	11.65M	16M	18.99M	24.13M	27.81M
Amortization of Goodwill and Intangible Assets - (IS)	7.88M	5.11M	3.35M	2.2M	1.44M
Other Operating Expenses	293M	373M	493M	723M	771M
Other Operating Expenses, Total	404M	503M	646M	911M	980M
Operating Income	167M	199M	279M	337M	447M
Interest Expense, Total	-	-105K	-2.9M	-488K	-
Interest And Investment Income	307K	-	-	-	25M
Net Interest Expenses	307K	-105K	-2.9M	-488K	25M
Currency Exchange Gains (Loss)	514K	2.78M	3.86M	-1.93M	-496K
Other Non Operating Income (Expenses)	669K	563K	3.21M	1.27M	4.55M
EBT, Excl. Unusual Items	169M	202M	283M	336M	476M
Impairment of Goodwill	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	169M	202M	283M	336M	476M
Income Tax Expense	23.15M	20M	37.49M	52.87M	71.54M
Earnings From Continuing Operations	145M	182M	245M	283M	404M
Net Income to Company	145M	182M	245M	283M	404M
Net Income - (IS)	145M	182M	245M	283M	404M
Preferred Dividend and Other Adjustments	459K	458K	157K	191K	44K
Net Income to Common Incl Extra Items	145M	181M	245M	283M	404M
Net Income to Common Excl. Extra Items	145M	181M	245M	283M	404M
Per Share Items
Net EPS - Basic	4.07	5.06	7.57	9.2	13.06
Basic EPS - Continuing Operations	4.07	5.06	7.57	9.2	13.06
Basic Weighted Average Shares Outstanding	35.64M	35.86M	32.39M	30.72M	30.96M
Net EPS - Diluted	3.84	4.81	7.28	8.88	12.63
Diluted EPS - Continuing Operations	3.84	4.81	7.28	8.88	12.63
Diluted Weighted Average Shares Outstanding	37.71M	37.7M	33.67M	31.84M	32.01M
Normalized Basic EPS	2.96	3.52	5.46	6.83	9.61
Normalized Diluted EPS	2.79	3.35	5.25	6.59	9.29
Supplemental Items
EBITDA	187M	220M	301M	363M	476M
EBITA	175M	204M	282M	339M	448M
EBIT	167M	199M	279M	337M	447M
EBITDAR	212M	250M	335M	401M	519M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	13.74	9.91	13.25	15.75	15.03
Current Domestic Taxes	20.99M	54.54M	57.15M	73.23M	92.28M
Current Foreign Taxes	1.59M	2.58M	3.33M	4.62M	5.88M
Total Current Taxes	22.58M	57.12M	60.48M	77.85M	98.16M
Deferred Domestic Taxes	531K	-36.3M	-23M	-25.99M	-25.54M
Deferred Foreign Taxes	38K	-820K	13K	1.01M	-1.08M
Total Deferred Taxes	569K	-37.12M	-22.99M	-24.98M	-26.62M
Normalized Net Income	105M	126M	177M	210M	297M
Supplemental Operating Expense Items
Advertising Expense	700K	1.2M	1.3M	1.5M	1.5M
Selling and Marketing Expenses	700K	1.2M	1.3M	1.5M	1.5M
Net Rental Expense, Total	25.18M	30.5M	34.44M	37.37M	43M
Imputed Operating Lease Interest Expense	-	184K	4.5M	783K	-
Imputed Operating Lease Depreciation	-	30.32M	29.94M	36.59M	-
Stock-Based Comp., COGS (Total)	7.78M	9.34M	11.8M	11.1M	11.12M
Stock-Based Comp., SG&A Exp. (Total)	6M	5.12M	9.61M	9.42M	14.4M
Total Stock-Based Compensation	13.78M	14.47M	21.41M	20.52M	25.51M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	278M	461M	28.26M	245M	669M
Total Cash And Short Term Investments	278M	461M	28.26M	245M	669M
Accounts Receivable, Total	161M	186M	253M	298M	297M
Other Receivables	-	-	11.3M	12.2M	24.1M
Notes Receivable	-	-	-	300K	-
Total Receivables	161M	186M	265M	311M	321M
Prepaid Expenses	34.92M	43.18M	40.99M	37.48M	39.15M
Restricted Cash	-	-	-	-	-
Total Current Assets	474M	691M	334M	594M	1.03B
Gross Property Plant And Equipment	238M	274M	311M	345M	351M
Accumulated Depreciation	-39.11M	-51.1M	-62.12M	-79.4M	-98.87M
Net Property Plant And Equipment	199M	223M	249M	265M	252M
Goodwill	662M	662M	662M	662M	662M
Other Intangibles, Total	46.47M	41.36M	38.01M	35.81M	34.37M
Deferred Tax Assets Long-Term	536K	25.13M	48.08M	74.44M	100M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	8.79M	17.42M	21.13M	24.97M	22.25M
Total Assets	1.39B	1.66B	1.35B	1.66B	2.1B
Liabilities
Accounts Payable, Total	26.55M	25.68M	33.07M	31.87M	32.53M
Accrued Expenses, Total	134M	159M	223M	293M	308M
Short-term Borrowings	-	-	50M	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	15.89M	16.28M	19.27M	22.36M	23.29M
Unearned Revenue Current, Total	256M	345M	463M	560M	711M
Other Current Liabilities	7.64M	11.34M	15.78M	18.08M	30.34M
Total Current Liabilities	440M	557M	803M	925M	1.1B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	115M	131M	139M	142M	126M
Deferred Tax Liability Non Current	13.55M	1.08M	1.07M	2.4M	1.8M
Other Non Current Liabilities	16.09M	17.74M	22.7M	28.22M	42.73M
Total Liabilities	585M	707M	966M	1.1B	1.28B
Common Stock, Total	355K	360K	309K	308K	306K
Additional Paid In Capital	696M	728M	771M	803M	844M
Retained Earnings	115M	235M	-360M	-222M	8.17M
Treasury Stock	-5.58M	-5.43M	-12.5M	-12.32M	-12.24M
Comprehensive Income and Other	-131K	-4.85M	-12.39M	-10.07M	-14.74M
Total Common Equity	806M	953M	386M	559M	826M
Total Equity	806M	953M	386M	559M	826M
Total Liabilities And Equity	1.39B	1.66B	1.35B	1.66B	2.1B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	35.73M	35.23M	31.05M	30.69M	30.47M
ECS Total Common Shares Outstanding	35.33M	35.83M	31.02M	30.68M	30.56M
Book Value / Share	22.8	26.6	12.46	18.22	27.01
Tangible Book Value	96.91M	249M	-314M	-139M	129M
Tangible Book Value Per Share	2.74	6.95	-10.12	-4.54	4.21
Total Debt	131M	147M	208M	164M	150M
Net Debt	-147M	-314M	180M	-80.96M	-520M
Debt Equivalent Oper. Leases	201M	244M	276M	299M	344M
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	2.49M	2.45M	2.41M	4.83M	5.03M
Buildings, Total	14.31M	13.77M	13.59M	16.42M	15.82M
Machinery, Total	103M	118M	145M	172M	180M
Full Time Employees	3.6K	4.5K	5.2K	5.9K	5.9K
Accumulated Allowance for Doubtful Accounts (Supple)	346K	171K	170K	7K	-
Order Backlog	1.54B	2B	2.34B	2.81B	2.9B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	145M	182M	245M	283M	404M
Depreciation & Amortization - CF	11.65M	16M	18.99M	24.13M	27.81M
Amortization of Goodwill and Intangible Assets - (CF)	7.88M	5.11M	3.35M	2.2M	1.44M
Depreciation & Amortization, Total	19.53M	21.12M	22.34M	26.33M	29.25M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	13.78M	14.47M	21.41M	20.52M	25.51M
Other Operating Activities, Total	13.72M	-20.82M	-7.13M	-2.77M	-7.52M
Change In Accounts Receivable	-5.53M	-24.98M	-66.92M	-48.28M	2.24M
Change In Accounts Payable	-2.6M	1.87M	6.43M	1.05M	-2.96M
Change in Unearned Revenues	63.41M	88.98M	118M	97.13M	151M
Change in Other Net Operating Assets	10.98M	846K	48.46M	56.59M	7.18M
Cash from Operations	259M	263M	388M	433M	609M
Capital Expenditure	-31.34M	-28.27M	-36.88M	-36.65M	-36.55M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Other Investing Activities, Total	126K	-3.09M	-1.86M	2.02M	8.24M
Cash from Investing	-31.21M	-31.36M	-38.74M	-34.63M	-28.31M
Short Term Debt Issued, Total	-	-	324M	105M	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	324M	105M	-
Short Term Debt Repaid, Total	-	-	-274M	-155M	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-274M	-155M	-
Issuance of Common Stock	15.99M	17.64M	22.07M	11.38M	15.86M
Repurchase of Common Stock	-98.27M	-62.1M	-848M	-144M	-170M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-82.28M	-44.45M	-776M	-183M	-154M
Foreign Exchange Rate Adjustments	666K	-3.97M	-6.57M	1.08M	-2.51M
Net Change in Cash	146M	184M	-433M	217M	424M
Supplemental Items
Cash Interest Paid	104K	123K	2.94M	3.06M	171K
Cash Income Tax Paid (Refund)	23.1M	56.24M	50.16M	76.35M	83.57M
Levered Free Cash Flow	188M	214M	296M	346M	465M
Unlevered Free Cash Flow	188M	214M	298M	347M	465M
Change In Net Working Capital	-81.42M	-83M	-117M	-126M	-167M
Net Debt Issued / Repaid	-	-	50M	-50M	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	8.24	8.14	11.56	13.99	14.87
Return on Total Capital	12.14	12.19	20.56	31.95	32.89
Return On Equity %	18.98	20.68	36.64	59.83	58.42
Return on Common Equity	18.92	20.63	36.62	59.79	58.41
Margin Analysis
Gross Profit Margin %	61.72	61.39	63.36	66.16	67.66
SG&A Margin	9.95	9.49	9	8.56	8.54
EBITDA Margin %	20.15	19.23	20.62	19.26	22.58
EBITA Margin %	18.89	17.83	19.32	17.98	21.26
EBIT Margin %	18.04	17.39	19.09	17.86	21.19
Income From Continuing Operations Margin %	15.7	15.92	16.81	15	19.17
Net Income Margin %	15.7	15.92	16.81	15	19.17
Net Avail. For Common Margin %	15.65	15.88	16.8	14.99	19.17
Normalized Net Income Margin	11.38	11.04	12.11	11.12	14.1
Levered Free Cash Flow Margin	20.28	18.77	20.3	18.36	22.03
Unlevered Free Cash Flow Margin	20.28	18.77	20.43	18.38	22.03
Asset Turnover
Asset Turnover	0.73	0.75	0.97	1.25	1.12
Fixed Assets Turnover	6.21	5.42	6.19	7.33	8.15
Receivables Turnover (Average Receivables)	5.85	6.58	6.64	6.84	7.09
Short Term Liquidity
Current Ratio	1.08	1.24	0.42	0.64	0.93
Quick Ratio	1	1.16	0.36	0.6	0.9
Operating Cash Flow to Current Liabilities	0.59	0.47	0.48	0.47	0.55
Days Sales Outstanding (Average Receivables)	62.58	55.5	54.98	53.4	51.64
Average Days Payable Outstanding	25.28	21.61	20.04	18.57	17.28
Long Term Solvency
Total Debt/Equity	16.26	15.45	53.87	29.43	18.11
Total Debt / Total Capital	13.99	13.38	35.01	22.74	15.33
LT Debt/Equity	14.29	13.74	35.94	25.43	15.29
Long-Term Debt / Total Capital	12.29	11.9	23.36	19.65	12.95
Total Liabilities / Total Assets	42.06	42.59	71.43	66.26	60.7
EBIT / Interest Expense	-	1.89K	95.94	690.22	-
EBITDA / Interest Expense	-	2.38K	115.48	820.75	-
(EBITDA - Capex) / Interest Expense	-	2.11K	102.79	745.65	-
Total Debt / EBITDA	0.62	0.59	0.62	0.41	0.29
Net Debt / EBITDA	-0.69	-1.26	0.54	-0.2	-1
Total Debt / (EBITDA - Capex)	0.73	0.66	0.7	0.45	0.31
Net Debt / (EBITDA - Capex)	-0.81	-1.41	0.6	-0.22	-1.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.54	23.38	27.8	29.17	11.84
Gross Profit, 1 Yr. Growth %	5.84	22.71	31.92	34.86	14.38
EBITDA, 1 Yr. Growth %	24.01	17.78	37	20.63	31.11
EBITA, 1 Yr. Growth %	23.1	16.47	38.44	20.2	32.24
EBIT, 1 Yr. Growth %	31.26	18.9	40.32	20.86	32.67
Earnings From Cont. Operations, 1 Yr. Growth %	44.74	25.08	34.93	15.26	42.99
Net Income, 1 Yr. Growth %	44.74	25.08	34.93	15.26	42.99
Normalized Net Income, 1 Yr. Growth %	35.01	19.77	40.13	18.67	41.78
Diluted EPS Before Extra, 1 Yr. Growth %	43.82	25.26	51.35	21.98	42.23
Accounts Receivable, 1 Yr. Growth %	3.4	15.82	35.92	17.76	-0.69
Net Property, Plant and Equip., 1 Yr. Growth %	99.94	12.01	11.77	6.62	-4.95
Total Assets, 1 Yr. Growth %	21.66	19.36	-18.52	22.5	26.8
Tangible Book Value, 1 Yr. Growth %	916.14	157.12	-226.02	-55.65	-192.48
Common Equity, 1 Yr. Growth %	10.95	18.26	-59.45	44.66	47.7
Cash From Operations, 1 Yr. Growth %	28.14	1.8	47.36	11.68	40.48
Capital Expenditures, 1 Yr. Growth %	74.97	-9.79	30.45	-0.63	-0.27
Levered Free Cash Flow, 1 Yr. Growth %	23.25	14.16	38.26	16.83	34.16
Unlevered Free Cash Flow, 1 Yr. Growth %	23.23	14.2	39.07	16.22	34.04
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.64	15.19	25.57	28.48	20.19
Gross Profit, 2 Yr. CAGR %	12.41	13.96	27.23	33.38	24.2
EBITDA, 2 Yr. CAGR %	15.5	20.85	27.03	28.56	25.76
EBITA, 2 Yr. CAGR %	15.73	19.74	26.98	29	26.07
EBIT, 2 Yr. CAGR %	28.57	24.93	29.17	30.23	26.63
Earnings From Cont. Operations, 2 Yr. CAGR %	40.94	34.55	29.91	24.71	28.38
Net Income, 2 Yr. CAGR %	40.94	34.55	29.91	24.71	28.38
Normalized Net Income, 2 Yr. CAGR %	33.93	27.16	29.55	28.96	29.71
Diluted EPS Before Extra, 2 Yr. CAGR %	39.62	34.22	37.69	35.87	31.72
Accounts Receivable, 2 Yr. CAGR %	9.83	9.44	25.47	26.51	8.18
Net Property, Plant and Equip., 2 Yr. CAGR %	95.06	49.65	11.89	9.16	0.67
Total Assets, 2 Yr. CAGR %	19.86	20.51	-1.38	-0.09	24.63
Tangible Book Value, 2 Yr. CAGR %	-16.94	411.14	80.01	-25.24	-35.96
Common Equity, 2 Yr. CAGR %	16.89	14.55	-30.75	-23.41	46.17
Cash From Operations, 2 Yr. CAGR %	28.53	14.21	22.48	28.29	25.26
Capital Expenditures, 2 Yr. CAGR %	39.85	25.63	8.48	13.86	-0.45
Levered Free Cash Flow, 2 Yr. CAGR %	26.57	18.62	25.63	27.09	25.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	24.22	18.63	26.02	27.13	24.81
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	33.81	17.48	19.25	26.76	22.68
Gross Profit, 3 Yr. CAGR %	48.45	15.74	19.66	29.72	26.72
EBITDA, 3 Yr. CAGR %	18.78	16.26	26.01	24.86	29.4
EBITA, 3 Yr. CAGR %	19.4	15.97	25.68	24.68	30.07
EBIT, 3 Yr. CAGR %	37.07	25.26	29.86	26.34	31.04
Earnings From Cont. Operations, 3 Yr. CAGR %	54.89	35.44	34.68	24.83	30.53
Net Income, 3 Yr. CAGR %	54.89	35.44	34.68	24.83	30.53
Normalized Net Income, 3 Yr. CAGR %	43.57	29.04	31.35	25.82	33.1
Diluted EPS Before Extra, 3 Yr. CAGR %	57.65	34.66	39.7	32.24	37.96
Accounts Receivable, 3 Yr. CAGR %	24.66	11.79	17.64	22.85	16.73
Net Property, Plant and Equip., 3 Yr. CAGR %	59.78	62.13	35.78	10.1	4.24
Total Assets, 3 Yr. CAGR %	13.52	19.7	5.77	6.01	8.17
Tangible Book Value, 3 Yr. CAGR %	-27.68	21.06	220.51	12.84	-19.75
Common Equity, 3 Yr. CAGR %	16.97	17.35	-18.97	-11.48	-4.67
Cash From Operations, 3 Yr. CAGR %	38.49	18.92	24.34	18.77	32.23
Capital Expenditures, 3 Yr. CAGR %	38.78	20.83	27.22	5.35	8.94
Levered Free Cash Flow, 3 Yr. CAGR %	29.81	22.29	24.84	22.63	29.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	27.82	20.79	25.08	22.66	29.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	23.67	25.25	30.45	21.76	19.62
Gross Profit, 5 Yr. CAGR %	29.59	32.44	39.57	22.5	21.45
EBITDA, 5 Yr. CAGR %	12.7	14.72	22.01	21.03	25.91
EBITA, 5 Yr. CAGR %	12.7	14.58	22.38	21.02	25.84
EBIT, 5 Yr. CAGR %	38.25	30.49	33.85	27.23	28.56
Earnings From Cont. Operations, 5 Yr. CAGR %	75.74	68.41	44.37	31.04	32.12
Net Income, 5 Yr. CAGR %	75.74	68.41	44.37	31.04	32.12
Normalized Net Income, 5 Yr. CAGR %	104.75	43.93	37.79	29	30.69
Diluted EPS Before Extra, 5 Yr. CAGR %	68.82	67.03	49.34	35.14	36.45
Accounts Receivable, 5 Yr. CAGR %	19.85	18.51	24.99	17.46	13.76
Net Property, Plant and Equip., 5 Yr. CAGR %	39.59	38.43	38.56	38.4	20.46
Total Assets, 5 Yr. CAGR %	7.16	11.14	7.3	11.35	12.94
Tangible Book Value, 5 Yr. CAGR %	-25.92	5.98	4.15	-0.17	68.3
Common Equity, 5 Yr. CAGR %	14.28	9.31	-5.16	-1.07	2.6
Cash From Operations, 5 Yr. CAGR %	24.68	23.48	31.85	22.58	24.7
Capital Expenditures, 5 Yr. CAGR %	37.12	15.87	25.76	17.99	15.33
Levered Free Cash Flow, 5 Yr. CAGR %	15.95	20.26	28.12	24.19	24.98
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.55	17.74	27.1	23.28	24.98